Search

Your search keyword '"Warner, Andrew"' showing total 40 results

Search Constraints

Start Over You searched for: Author "Warner, Andrew" Remove constraint Author: "Warner, Andrew" Language undetermined Remove constraint Language: undetermined
40 results on '"Warner, Andrew"'

Search Results

3. Additional file 1 of Is hypofractionated whole pelvis radiotherapy (WPRT) as well tolerated as conventionally fractionated WPRT in prostate cancer patients? The HOPE trial

4. Additional file 5 of Treatment de-escalation for HPV-associated oropharyngeal squamous cell carcinoma with radiotherapy vs. trans-oral surgery (ORATOR2): study protocol for a randomized phase II trial

5. Additional file 4 of Preservation of swallowing in resected oral cavity squamous cell carcinoma: examining radiation volume effects (PRESERVE): study protocol for a randomized phase II trial

6. Additional file 3 of Preservation of swallowing in resected oral cavity squamous cell carcinoma: examining radiation volume effects (PRESERVE): study protocol for a randomized phase II trial

7. Additional file 4 of Treatment de-escalation for HPV-associated oropharyngeal squamous cell carcinoma with radiotherapy vs. trans-oral surgery (ORATOR2): study protocol for a randomized phase II trial

8. Additional file 6 of Treatment de-escalation for HPV-associated oropharyngeal squamous cell carcinoma with radiotherapy vs. trans-oral surgery (ORATOR2): study protocol for a randomized phase II trial

9. Combined_supplemental_materials-Edmondson_et_al - Naturally Acquired Mouse Kidney Parvovirus Infection Produces a Persistent Interstitial Nephritis in Immunocompetent Laboratory Mice

10. Additional file 2 of Preservation of swallowing in resected oral cavity squamous cell carcinoma: examining radiation volume effects (PRESERVE): study protocol for a randomized phase II trial

11. Additional file 1 of Treatment de-escalation for HPV-associated oropharyngeal squamous cell carcinoma with radiotherapy vs. trans-oral surgery (ORATOR2): study protocol for a randomized phase II trial

12. Additional file 1 of Preservation of swallowing in resected oral cavity squamous cell carcinoma: examining radiation volume effects (PRESERVE): study protocol for a randomized phase II trial

13. Additional file 2 of Treatment de-escalation for HPV-associated oropharyngeal squamous cell carcinoma with radiotherapy vs. trans-oral surgery (ORATOR2): study protocol for a randomized phase II trial

14. Additional file 3 of Treatment de-escalation for HPV-associated oropharyngeal squamous cell carcinoma with radiotherapy vs. trans-oral surgery (ORATOR2): study protocol for a randomized phase II trial

15. Additional file 1: of Stereotactic ablative radiotherapy for the comprehensive treatment of 4â 10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial

16. Additional file 3: of Stereotactic ablative radiotherapy for the comprehensive treatment of 4â 10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial

17. Additional file 2: of Stereotactic ablative radiotherapy for the comprehensive treatment of 4â 10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial

18. Additional file 3: of A prospective phase I dose-escalation trial of stereotactic ablative radiotherapy (SABR) as an alternative to cytoreductive nephrectomy for inoperable patients with metastatic renal cell carcinoma

22. Fundamental

24. Measuring the Shadow Economy in Bulgaria

26. Achieving Rapid Growth in the Transition Economies of Central Europe

28. Macroeconomic effects of terms-of-trade shocks : the case of oil-exporting countries

29. How should sovereign debtors restructure their debts? Fixed interest rates, flexible interest rates, or inflation - indexed

30. Did the debt crisis or declining oil prices cause Mexico's investment collapse?

31. MOESM6 of Genomic and human papillomavirus profiling of an oral cancer cohort identifies TP53 as a predictor of overall survival

32. MOESM5 of Genomic and human papillomavirus profiling of an oral cancer cohort identifies TP53 as a predictor of overall survival

33. Additional file 1 of Stereotactic ablative radiotherapy for the comprehensive treatment of 1–3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trial

34. Additional file 1 of Stereotactic ablative radiotherapy for the comprehensive treatment of 1–3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trial

35. Additional file 1: of Cancer targeting by TCR gene-engineered T cells directed against Kita-Kyushu Lung Cancer Antigen-1

36. MOESM4 of Genomic and human papillomavirus profiling of an oral cancer cohort identifies TP53 as a predictor of overall survival

37. MOESM4 of Genomic and human papillomavirus profiling of an oral cancer cohort identifies TP53 as a predictor of overall survival

38. Additional file 1: of Cancer targeting by TCR gene-engineered T cells directed against Kita-Kyushu Lung Cancer Antigen-1

39. MOESM5 of Genomic and human papillomavirus profiling of an oral cancer cohort identifies TP53 as a predictor of overall survival

40. MOESM6 of Genomic and human papillomavirus profiling of an oral cancer cohort identifies TP53 as a predictor of overall survival

Catalog

Books, media, physical & digital resources